Synlett 2009(17): 2849-2851  
DOI: 10.1055/s-0029-1217963
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Enantioselective Synthesis of the Sporolide Quinone Acid Fragment

Jean-Yves Wach, Karl Gademann*
Swiss Federal Institute of Technology (EPFL), Chemical Synthesis Laboratory (ISIC-LSYNC), 1015 Lausanne, Switzerland
Fax: +41(21)6939700; e-Mail: karl.gademann@epfl.ch;
Further Information

Publication History

Received 10 July 2009
Publication Date:
09 September 2009 (online)

Abstract

The sporolide quinone acid is a key fragment in the biosynthesis of the complex heptacyclic marine metabolite sporolide. We report a concise enantioselective route to this fragment, which is obtained in seven steps with 65% overall yield from trimethoxybenzene. The enantioselective transfer reduction is achieved by Ipc2BCl, and the absolute configuration of the product secured by X-ray analysis of its cinchonine salt. The target fragment is then obtained by methylation and oxidation to the quinone by AgO.

    References and Notes

  • 1 Buchanan GO. Williams PG. Feling RH. Kauffman CA. Jensen PR. Fenical W. Org. Lett.  2005,  7:  2731 
  • 2a Oh DC. Williams PG. Kauffman CA. Jensen PR. Fenical W. Org. Lett.  2006,  8:  1021 
  • 2b Udwary DW. Zeigler L. Asolkar RN. Singan V. Lapidus A. Fenical W. Jensen PR. Moore BS. Proc. Natl. Acad. Sci., U.S.A.  2007,  104:  10376 
  • 2c Perrin CL. Rodgers BL. O’Connor J. M. J. Am. Chem. Soc.  2007,  129:  4795 
  • 2d McGlinchey RP. Nett M. Moore B. J. Am. Chem. Soc.  2008,  130:  2406 
  • 2e Review: Fenical W. Jensen PR. Nature Chem. Biol.  2006,  2:  666 
  • 3a Nicolaou KC. Wang J. Tang Y. Angew. Chem. Int. Ed.  2008,  47:  1432 
  • 3b Nicolaou KC. Tang Y. Wang J. Angew. Chem. Int. Ed.  2009,  48:  3449 
  • 4 Carmen Carreno M. Garcia Ruano JL. Toledo MA. Urbano A. Tetrahedron: Asymmetry  1997,  8:  913 
  • 5 Yoshikawa N. Doyle A. Tan L. Murry JA. Akao A. Kawasaki M. Sato K. Org. Lett.  2007,  9:  4103 
  • 6a Itsuno S. Kito K. Hirao A. Nakahama S. J. Chem. Soc., Chem. Commun.  1983,  469 
  • 6b Corey EJ. Shibata S. Bakshi RK. J. Org. Chem.  1988,  53:  2861 
  • 7 Gathergood N. Zhuang W. Jørgensen KA. J. Am. Chem. Soc.  2000,  122:  12517 
  • 8a Brown HC. Ramachandran PV. Acc. Chem. Res.  1992,  25:  16 
  • 8b Ramachandran PV. Brown HC. Pitre S. Org. Lett.  2001,  3:  17 
  • 9a Snyder CD. Rapoport H. J. Am. Chem. Soc.  1972,  94:  227 
  • 9b Hauser FM. Rhee RP. J. Org. Chem.  1980,  45:  3061 
10

Preparation and Selected Data for Compound 4
A solution of 2-oxo-2-(2,4,5-trimethoxy-3-methylphenyl)-acetic acid (300 mg, 1.18 mmol, 1.0 equiv) in THF (6 mL) at -40 ˚C was treated with Et3N (164 mL, 1.18 mmol, 1.0 equiv) and stirred for 5 min followed by the slow addition of (-)-Ipc2BCl (417 mg, 1.30 mmol, 1.1 equiv) in THF (2 mL). The reaction mixture was gradually warmed up to r.t. and stirred at r.t. for 3 h. The reaction was quenched with H2O, treated with NaOH (10%) to pH >12, extracted with Et2O, and the organic layers were combined and washed with H2O (25 mL). The aqueous layers were then combined and acidified with 1 N HCl to pH 2 and extracted with EtOAc. The combined organic layers were washed with brine and dried over Na2SO4. Once concentrated, the crude hydroxy acid was purified by recrystallization from hot EtOH as its cyclohexylammonium salt. The title compound was then obtained (233 mg, 0.909 mmol, 77%) as a white crystalline solid by extraction with Et2O of the aqueous acid solution of the salt. R f  = 0.21 (CH2Cl2-MeOH-AcOH = 9:1:0.05); [α]D ²5 -81.6 (c 0.2325, CHCl3). ¹H NMR (400 MHz, CDCl3): δ = 6.89 (s, 1 H), 5.36 (s, 1 H), 3.84 (s, 6 H), 3.80 (s, 3 H), 2.24 (s, 3 H). ¹³C NMR (100 MHz, CDCl3):
δ = 193.66, 174.75, 150.16, 148.35, 125.78, 125.41, 107.98, 68.61, 61.33, 60.33, 55.99, 9.71. ESI-HRMS (TOF): m/z calcd for C12H16O6 [M + Na]+: 279.0845; found: 279.0834. IR: ν = 3429 (br m), 2994 (m), 2940 (m), 2858 (w), 1728 (s), 1597 (w), 1489 (s), 1462 (m), 1420 (m), 1335 (m), 1242 (s), 1123 (s), 1084 (s), 1007 (m) cm.

11

Preparation and Selected Data for Compound 1
To a stirred solution of (R)-methyl 2-methoxy-2-(2,4,5-trimethoxy-3-methylphenyl)acetate (5, 250 mg, 0.879 mmol, 1.0 equiv) in dioxane (4 mL) was added AgO (545 mg, 4.397 mmol, 5.0 equiv) followed by 4 N HNO3 until the silver oxide was completely dissolved. The resulting solution was stirred for 30 min and then diluted with CH2Cl2. The organic layer was washed with H2O, brine, dried over Na2SO4, and the solvent was evaporated under reduced pressure to afford the crude product, which was purified by chromatography using hexane-EtOAc (8:2) as eluent. The analytically pure product (188 mg, 0.782 mmol, 89%) was obtained as a red viscous oil. R f  = 0.50 (hexane-EtOAc = 1:1); [α]D ²5 -33.0 (c 0.36, CHCl3). ¹H NMR (400 MHz, CDCl3): δ = 6.85 (d, J = 1.3 Hz, 1 H), 4.90 (d, J = 1.3 Hz, 1 H), 3.77 (s, 3 H), 3.51 (s, 3 H), 1.96 (s, 3 H). ¹³C NMR (100 MHz, CDCl3): δ = 186.63, 183.06, 169.48, 151.73, 146.22, 128.88, 118.02, 76.81, 59.37, 53.25, 1.45. IR: ν = 3352 (w), 2955 (m), 2920 (s), 2851 (m), 1744 (s), 1659 (s), 1643 (s), 1620 (m), 1458 (w), 1393 (m), 1346 (m), 1269 (m), 1196 (s), 1157 (m), 1107 (m), 1045 (w), 1011 (w) cm.

12

Preparation and Selected Data for Compound 6
To a solution of (R)-methyl 2-(4-chloro-5-methyl-3,6-dioxocyclohexa-1,4-dienyl)-2-methoxyacetate (1, 46 mg, 0.193 mmol, 1.0 equiv) in dry CH2Cl2 (1.9 mL) at 0 ˚C was added oxalyl chloride (33 µL, 0.387 mmol, 2.0 equiv) followed by one drop of DMF. The reaction mixture was stirred for 1 h at 0 ˚C and 16 h at r.t. The reaction was quenched with H2O (3 mL), and the aqueous layer was extracted with CH2Cl2. The combined organic layers were dried over Na2SO4 and concentrated to afford the crude product, which was purified by chromatography using hexane-EtOAc (9:1) as eluent. The analytically pure product (42 mg, 0.162 mmol, 84%) was obtained as a red viscous oil. R f  = 0.71 (hexane-EtOAc = 1:1); [α]D ²5 -48.0 (c 0.27, CHCl3). ¹H NMR (400 MHz, CDCl3): δ = 7.00 (d, J = 1.2 Hz, 1 H), 4.88 (d, J = 1.2 Hz, 1 H), 3.80 (s, 3 H), 3.54 (s, 3 H), 2.24 (s, 3 H). ¹³C NMR (100 MHz, CDCl3): δ = 183.56, 178.92, 173.23, 168.85, 143.69, 142.41, 132.61, 76.27, 59.05, 52.88, 13.75. ESI-HRMS (TOF): m/z calcd for C11H11ClO5 [M + Na]+: 281.0187; found: 281.0189. IR: ν = 2955 (w), 2924 (w), 2847 (w), 2361 (w), 2338 (w), 1748 (s), 1670 (s), 1605 (w), 1439 (w), 1373 (w), 1277 (m), 1246 (m), 1204 (m), 1165 (w), 1111 (m), 1015 (w) cm.